INTRODUCTION
============

During the last decades the definition of peri-implantitis has suffered several modifications with the development in the understanding of dental implantology and its biological implications. Recently, as described by the American Academy of Periodontology \[[@B1]\] mucositis is defined as an inflammatory process around a dental implant without loss of supporting bone beyond biological bone remodelling. On the other hand, peri-implantitis is characterized by both, inflammation of the surrounding peri-implant tissues and loss of supporting bone beyond initial biological bone remodelling. Nonetheless recent investigations have recognized at least 7 definitions of peri-implantitis based on the extension and severity of the bone loss \[[@B2]\]. These interpretations of the peri-implant disease certainly reflect the multifactorial nature of the entity, displaying a multitude of clinical presentations. Hence, it is reasonable to assume that further definitions will appear in upcoming years as we continue performing research in the field. Nonetheless, the complex mechanisms that influence initial bone remodelling, among other variables, will certainly ensure this to be a challenging duty.

With regard to the treatment of the peri-implant diseases, a variety of different approaches have been proposed including but not limited to: non-surgical therapy; surgical management by means of access flap debridement, lasers disinfection, implantoplasty, resective procedures, as well as regenerative approaches \[[@B3]\]. While most of the available evidence agrees on the effectiveness of non-surgical therapy for mucositis lesions \[[@B4]\], conflicting results are found when trying to identify the most effective protocol for peri-implantitis \[[@B3],[@B5]\]. In this sense, a recent systematic review evaluating the effectiveness of peri-implantitis treatment has shown that reconstructive procedures do not result in more optimal outcomes when compared to non-reconstructive procedures \[[@B5]\]. This result is in concordance with the majority of the literature available with regard to peri-implantitis treatment which presents with great variability in terms of treatment outcomes. These inconsistencies can be attributed to a variety of different factors, including but not limited to: different aetiologies and contributing factors affecting dental implants, morphology of the defects, case description/selection, implant positioning, and the influence of different implant surfaces.

Non-surgical therapy for peri-implant diseases has traditionally been considered effective for mucositis. However, results for peri-implantitis lesions were found not to be effective \[[@B4]\]. Surprisingly, newer studies have challenged again this hypothesis achieving exceptional results after non-surgical decontamination of peri-implantitis lesions \[[@B6]\].

Due to the increasing prevalence of both peri-implant mucositis and peri-implantitis, there is an urgent need to understand its aetiology and the multiples variables affecting it development and progression leading to the generation of more predictable treatment approached. Hence, the aim of the present review was to systematically evaluate the effectiveness of current (last 5 years) methodologies for the non-surgical treatment of peri-implant diseases.

MATERIAL AND METHODS
====================

**Protocol and registration**

The methods as well as inclusion/exclusion criteria employed for the present review were determined in advance. This protocol was registered in an international prospective register of systematic reviews 'PROSPERO' with the following registration number: CRD42016037631. The current systematic review was performed by two independent reviewers following the PRISMA guidelines for identification, screening, eligibility, and inclusion \[[@B7]\].

Focus question

The following focus question was developed according to the population, intervention, comparison, and outcome (PICO) study design: In patient suffering from peri-implant mucositis or peri-implantitis, what is the effectiveness of non-surgical therapy by means of different techniques and/or approaches for clinical and radiographically resolution of disease, including bleeding on probing (BOP), probing pocket depth (PPD), and radiographic bone (RB) level changes.

**Information sources**

The search strategy consisted in the examination of several databases as well as manual screening. The electronic search was performed in several databases, including MEDLINE (PubMed), and EMBASE databases for articles from 2011 up to April 2016 with limitation to English language. Additionally, a manual search of periodontics/implantology-related journals, including "Clinical Oral Implant Research", "Journal of Dental Research", "Journal of Clinical Periodontology", "Journal of Periodontology", "Clinical Implant Dentistry and Related Research", and "The International Journal of Periodontics & Restorative Dentistry", from 2011 up to April 2016 was also performed to ensure a thorough screening process. Furthermore, references of all articles reviewed in full text were further screened.

**Search**

Both PubMed and EMBASE databases were screened through advances searchers. For the PubMed library, combinations of controlled terms (MeSH and EMTREE) and keywords were used whenever possible. Into the addition, other terms not indexed as MeSH and filters were applied. As such, the key terms used were: ((((((((((((("non-surgical") OR "dental prophylaxis" \[MeSH Terms\]) OR "dental scaling" \[MeSH Terms\]) OR "scaling, subgingival" \[MeSH Terms\]) OR "dental polishing" \[MeSH Terms\]) OR "diode lasers" \[MeSH Terms\]) OR "yag laser, erbium" \[MeSH Terms\]) OR "antibiotic prophylaxis" \[MeSH Terms\]) OR "agents, local anti infective" \[MeSH Terms\]) AND "periimplantitis" \[MeSH Terms\]) OR "peri-implant mucositis") OR "peri-implant maintenance") OR "implant infection") OR "peri-implant infection" AND ("last 5 years" \[PDat\] AND "Humans" \[Mesh\]). On the other hand, for EMBASE for following terms were employed: "non-surgical"' OR "scaling"' OR "laser/exp" OR "laser" OR "subgingival curettage/exp" OR "subgingival curettage" AND ("periimplantitis/exp" OR "'periimplantitis") OR "peri-implant mucositis".

**Selection of studies**

Titles and abstracts derived from the search were independently screened by two reviewers (FSLA and SHY) based on the inclusion criteria. Both reviewers compared decisions and their eligibility for this review was confirmed after discussion. Full articles were obtained for all the investigations deemed eligible for inclusion in this paper and further evaluated by both reviewers. If needed, a third party was consulted when consensus could not be reached.

Types of publications

The present review included only human studies published in the English language. Letters, editorials, reviews and meta-analysis, PhD thesis, as well as abstracts were not evaluated.

**Types of studies**

The present investigation included cases series, prospective, as well randomized controlled trials (RCTs) published between 2011 and April of 2016 that reported on non-surgical treatment for peri-implant mucositis and peri-implantitis. Case report, retrospective, as well as studies with less than 10 implants or less than 6 months follow up were excluded.

Types of participants/population

Individuals included in the studies should have had at least one osseointegrated screw-type dental implant that presented with signs of peri-implant mucositis or peri-implantitis and received non-surgical treatment. Nonetheless, included investigations presented with different definitions for the diseases evaluated.

**Inclusion and exclusion criteria**

Articles were included in this systematic review if they met the following inclusion criteria:

-   Investigated non-surgical treatment outcomes for peri-implant mucositis and peri-implantitis in patients with at least one osseointegrated solid screw-type implant;

-   All human prospective studies, as well as clinical trials, cohort studies, case-control, and case series studies;

-   At least 10 implants;

-   At least 6 months follow-up;

-   Clinical and/or radiographic changes reported. Treatment outcomes reporting changes in PPDs and/or BOP and/or RB changes.

On the contrary, the following articles were excluded:

-   Care reports, retrospective investigations, *in vitro* and animal studies;

-   Less than 10 implants;

-   Less than 6 months of follow-up;

-   Surgical treatment for peri-implantitis;

-   Human trials with missing information or unclear data.

**Sequential search strategy**

Initial literature search was conducted in several databases including MEDLINE (PubMed) and EMBASE from 2011 to 2016. All articles titles were screened in order to eliminate non-qualifying studies. Next, screening of abstract was performed followed by elimination of non-qualifying investigations. Finally, full text evaluation of each article was performed in order to confirm the eligibility based on the inclusion and exclusion criteria. References of full text evaluated investigations were also performed. In addition, a manual search in periodontics/implantology-related journals, including "Clinical Oral Implant Research", "Journal of Dental Research", "Journal of Clinical Periodontology", "Journal of Periodontology", "Clinical Implant Dentistry and Related Research", and "The International Journal of Periodontics & Restorative Dentistry", from 2011 up to 2016, was also performed to ensure a thorough screening process.

**Data extraction**

Data were extracted from the included studies independently by two reviewers (FSLA and ESHY). If any disagreement occurred, a third reviewer was consulted (HLW).

**Assessment of methodological quality**

The quality of all selected RCTs was assessed using The Cochrane Collaboration's tool for assessing risk of bias in randomised trials \[[@B8]\]. Parameters evaluated included:

-   Random sequence generation;

-   Allocation concealment;

-   Blinding of participants and personnel;

-   Blinding of outcome assessment;

-   Incomplete outcome data;

-   Selective reporting;

-   Other bias.

The potential risk of bias was categorized as "low", "unclear" or "high" depending on the quality and detailed explanation of provided information about all abovementioned parameters. All assessments were completed by a single examiner (SHY). The Newcastle-Ottawa Scale (NOS) was used to evaluate the methodological quality of nonrandomized included studies \[[@B9]\]. The topics evaluated were selection of study groups, comparability of patients, and outcome. Each included study received a maximum of 10.

**Data analyses**

Significant heterogeneity between publications in terms of diseases definitions, study designs, patient and defect related characteristics, as well as measured outcomes, among others, prevented the quantitative synthesis of the included studies and consequently a meta-analysis could not be completed. Instead, a qualitative descriptive analysis of the reported outcomes was performed and systematically reviewed in forms of tables.

RESULTS
=======

**Study selection**

Initial screening of electronic databases yielded a total of 2837 articles. Additionally, 21 more articles were found through manual screening. After removal of duplicated studies, a total of 2625 titles and abstract were evaluated. Overall, a total of 26 potentially relevant articles were selected after an evaluation of their titles and abstracts. Full text of these articles was obtained and thoroughly evaluated. Of these, 14 studies fulfilled the inclusion criteria and were subsequently included in the systematic review ([Figure 1](#fig1){ref-type="fig"} and Tables [1A](#T1A){ref-type="table"}, [1B](#T1B){ref-type="table"}, [1C](#T1C){ref-type="table"}, [2](#T2){ref-type="table"}).

![PRISMA flowchart of the screening process in the different databases.](jomr-07-e13-g001){#fig1}

###### 

Characteristics of the included articles

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                     Year of\                            Type of\                                       Groups    Treatment provided                                                          N\                                                                            N\                     Follow-up\     Diagnosis                Treatment outcomes   Microbiological\   Conclusions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                            publication                         study                                                                                                                                patients                                                                      implants               (months)                                                     results                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  ------------------------- ----------------------------------- ---------------------------------------------- --------- --------------------------------------------------------------------------- ----------------------------------------------------------------------------- ---------------------- -------------- ------------------------ -------------------- ------------------ -------------------------------------------------------------------------------- ----------------- ------------------- ------------------------ ---------------------- -------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Arisan et al. \[20\]      2015                                RCT                                            Control   OHI                                                                         MD                                                                            5                      24             6                        Peri-implantitis     4.38 (0.42)\       2.35 (0.56)\                                                                     100 to 100%       NA                  91.7 to 41.7%            NA                     NA             No changes in microbiota\                                                                                                                                                                Laser does not provide any additional benefit when compared to SRP alone.                                                                      
                                                                                                                                                                                                                                                                                                                                                                       to\                to\                                                                                                                                                                                   after 1 month                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                       4.17 (0.41)        2.63 (0.53)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Test                      OHI                                 MD + diode laser 810 nm\                       5         24                                                                          4.71 (0.67)\                                                                  2.13 (0.47)\           100 to 95.8%   NA                       91.7 to 54.2%        NA                 NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                (energy density: 3 J/cm^2^;\                                                                                                         to\                                                                           to\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                                                time: 1 min;\                                                                                                                        4.54 (0.74)                                                                   2.79 (0.48)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                power density: 400 mW/cm^2^; energy: 1.5 J;\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                spot diameter: 1 mm)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Bassetti et al. \[21\]    2014                                RCT                                            Control   Instructions\                                                               MD + Airpolishing\                                                            20                     20             12                       Peri-implantitis     4.39 (0.77)\       NA                                                                               Sites:\           NA                  0.21 (0.27)\             2.72 (0.72)\           1.68 (1.04)\   *P. gingivalis*, *T. forsythia*, *T. denticola*, *C. rectus*, *F. nucleatum* and *E. corrodens* demonstrated statistically significant decrease from baseline.                           Similar results clinically and microbiologically for both.\                                                                                    
                                                                                                                         in the use of\                                                              + 3% hydrogen peroxide irrigation\                                                                                                                                to\                                                                                                 4.41 (1.47)\                          to\                      to\                    to\                                                                                                                                                                                                     Complete disease resolution not routinely achieved.                                                                                            
                                                                                                                         superfloss                                                                  + Arestin                                                                                                                                                         3.83 (0.85)                                                                                         to\                                   0 (0)                    2.41 (0.7)             1.41 (1.18)                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                           1.55 (1.26)\                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                           (65% reduction)                                                                                                                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Test                      MD + Airpolishing + PDT\            20                                             20        4.19 (0.55)\                                                                NA                                                                            Sites:\                NA             0.13 (0.21)\             2.66 (0.73)\         1.53 (0.91)\       No statistically significant difference with the exception for *F. nucleatum*.                                                                                                                                                                                                                                                                                                                                                                                                                                                
                            (660 nm, power density 100 mW)\                                                              to\                                                                                                                                                       4.03 (1.66)\                          to\                      to\                  to\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                            + 3% hydrogen peroxide irrigation                                                            4.08 (0.81)                                                                                                                                               to\                                   0.01 (0.04)              2.58 (0.94)          1.5 (0.86)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                   1.74 (1.37)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                   (57% reduction)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Esposito et al. \[22\]    2013                                RCT                                            Control   In surgery group: CHX mouthwash 0.12% for 1 min twice a day for 2 weeks.\   Bone loss between 3 - 5 mm:\                                                  No adjunct treatment   40             100                      12                   Peri-implantitis   6.45 (2.15)\                                                                     4.9 (2.07)\       Bleeding scores:\   NA                       Mean plaque scores:\   NA             NA                                                                                                                                                                                       NA                                                                                                                                             Adjunctive use of LAD therapy with mechanical debridement did not improve any clinical outcomes when compared to mechanical cleaning alone up to 1 year after treatment.
                                                                                                                         All gourps: gentle wiping with a soft brush                                 implant surface DE bone loss \> 5 mm: surgery, full-thickness flap and DE,\                                                                                                          to\                                                                              to\               2.68 (1.25)\                                 2.15 (1.64)\                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                     remove all granulation tissue                                                                                                                                                        5.5 (1.94)                                                                       5.03 (2.51)       to\                                          to\                                                                                                                                                                                                                                                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             1.28 (1.11)                                  0.93 (0.94)                                                                                                                                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Test                      LAD (FotoSan 630 instrument)        40                                             101       6.23 (1.62)\                                                                4.5 (1.75)\                                                                   Bleeding scores:\      NA             Mean plaque scores:\     NA                   NA                 NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                         to\                                                                         to\                                                                           2.95 (1.32) to\                       2.18 (1.53)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                                                                         5.14 (1.83)                                                                 4.5 (1.67)                                                                    1.35 (1.32)                           to\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                         0.89 (0.94)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Hallstrom et al. \[23\]   2012                                RCT                                            Control   OHI                                                                         MD with titanium curettes\                                                    21                     NA             6                        Mucositis            4.6 (0.9)\         NA                                                                               Full mouth\       NA                  Mean PI at implant %:\   NA                     NA             No significant differences in bacterial count. Statistical analysis by intent to treat failed to identify within group differences comparing baseline data with all other time points.   No short-term differences between groups. The clinical improvements observed at 6 months may be attributed to improvements in oral hygiene.\   
                                                                                                                                                                                                     + polishing                                                                                                                                                       to\                                                                                                 BOP %:\                               22 (29.2)\                                                                                                                                                                                                                                              No evidence for the use of systemic antibiotics in treatment of peri-implant mucositis.                                                        
                                                                                                                                                                                                                                                                                                                                                                       4.1 (1.2)                                                                                           24.2 (16.7)\                          to\                                                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                           to\                                   17.9 (28.4)                                                                                                                                                                                                                                                                                                                                                                                            
                                                                                                                                                                                                                                                                                                                                                                                                                                                                           18.4 (17.4)                                                                                                                                                                                                                                                                                                                                                                                                                                  

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Test                      MD with titanium curettes\          22                                             NA        4.4 (1)\                                                                    NA                                                                            Full mouth\            NA             Mean PI at implant %:\   NA                   NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
                            + polishing + ABX\                                                                           to\                                                                                                                                                       BOP %:\                               33.7 (35.5)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                            (Azithromycin® 500 mg day 1 and\                                                             3.5 (1.1)                                                                                                                                                 28.2 (20.6)\                          to\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                            250 mg days 2 - 4).                                                                                                                                                                                                                                    to\                                   6.8 (13.8)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                   10.1 (6.9)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ABX = antibiotics treatment; BOP = bleeding on probing; CAL = clinical attachment level; CHX = chlorhexidine digluconate; DE = debridement; LAD = light-activated disinfection; LD = local delivery; MBL = marginal bone level; MD = mechanical debridement; MPI = modified plaque index; NA = not available; OHI = oral hygiene instructions; PD = probing depth; PDT = photodynamic therapy; PI = plaque index; PR = prospective study; RB = radiographic bone; RCT = randomized controlled trials; SD = standard deviation.

###### 

Characteristics of the included articles

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                            Year of\                                                           Type of\                                                                                                                                 Groups                       Treatment provided                                                                                   N\                                                                                                                         N\                                                                                                           Follow-up\                                                                                          Diagnosis                    Treatment outcomes                   Microbiological\           Conclusions                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
                                   publication                                                        study                                                                                                                                                                                                                                                                      patients                                                                                                                   implants                                                                                                     (months)                                                                                                                                                              results                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  -------------------------------- ------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- ---------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------- ---------------------------- ------------------------------------ -------------------------- ------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------- ---------------------- ------------------------ ----------------- ---------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  John et al. \[24\]               2015                                                               RCT                                                                                                                                      AAD                          OHI on 2 to 4 appointments                                                                           Submucosal AAD employed with amino acid glycine powder (Air-Flow® Perio Powder, EMS)                                       12                                                                                                           18                                                                                                  12                           Peri-implantitis                     3.7 (1)\                   NA                                                                                                           99 (4.1)\                                                                                           NA                     1.2 (1.1)\               5.2 (1.9)\        1.5 (1.4)\             NA                                                                                                                                                                                                                                                 Both treatments resulted in comparable but limited CAL gains at 12 months. AAD was associated with significantly higher BOP decrease than MDA.
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               to\                                                                                                                                     to\                                                                                                                        to\                      to\               to\                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               3.2 (1.1)                                                                                                                               57.8 (30.7)%                                                                                                               1.8 (1.1)                4.6 (1.8)         1.4 (1.3)                                                                                                                                                                                                                                                                 

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  MD (carbon curettes\             OHI on 2 to 4 appointments                                         MD was performed using carbon curets followed by pocket irrigation with a 0.1 % CHX solution and submucosal application of 1 % CHX gel   13                           18                                                                                                   3.9 (1.1)\                                                                                                                 NA                                                                                                           94.7 (13.7)\                                                                                        NA                           1.2 (1)\                             5 (1.5)\                   1 (1.1)\                                                                                                     NA                                                                                                                                                                                                                                                                                                                                                                                                                                              
  + local antiseptic therapy)                                                                                                                                                                                                                                                                                                                                                    to\                                                                                                                                                                                                                                     to\                                                                                                                              to\                                  to\                        to\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                                                                 3.5 (1.2)                                                                                                                                                                                                                               78.1 (30)%                                                                                                                       0.9 (0.7)                            4.5 (1.3)                  0.9 (1.1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Machtei et al. \[25\]            2012                                                               Double-blind RCT                                                                                                                         Control                      OHI\                                                                                                 Surface MD+ biodegradable crosslinked gelatin matrix chip (placebo)                                                        30                                                                                                           37                                                                                                  6                            Peri-implantitis                     7.21\                      NA                                                                                                           100 to 42.5%                                                                                        NA                     NA                       7.63 (0.3)\       NA                     NA                                                                                                                                                                                                                                                 Substantial reduction in PD, gain in CAL and reduction in BOP in sites with peri-implantitis.
                                                                                                                                                                                                                                                                            patients were given sodium fluoride toothpaste                                                                                                                                                                                                                                                                                                                                                                                                                                                                     to\                                                                                                                                                                                                                                                                                         to\                                                                                                                                                                                                                                                                                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               5.48                                                                                                                                                                                                                                                                                        5.94 (0.3)                                                                                                                                                                                                                                                                                  

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Test                             OHI\                                                               Surface MD+ matrix containing 2.5 mg CHX chips                                                                                           30                           40                                                                                                   7.60\                                                                                                                      NA                                                                                                           100 to 59%                                                                                          NA                           NA                                   7.88 (0.2)\                NA                                                                                                           NA                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                   patients were given sodium fluoride toothpaste                                                                                                                                                                                                                                                                                                to\                                                                                                                                                                                                                                                                                                                                                                                                           to\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                 5.47                                                                                                                                                                                                                                                                                                                                                                                                          5.7 (0.3)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Persson et al. \[26\]            2011                                                               RCT                                                                                                                                      Er:YAG laser                 OHI and patients received a sonic toothbrush                                                         (Er:YAG) laser: 100 mJ/pulse and 10 Hz (12.7 J/cm^2^)                                                                      21                                                                                                           55                                                                                                  6                            Peri-implantitis                     PD reductions: 0.9 (0.8)   Statistical analyses failed to demonstrate differences in bone-level changes between baseline and 6 months   Statistical analyses also failed to demonstrate differences in the BOP at 6 weeks after treatment   NA                     NA                       NA                NA                     Both treatments failed to reduce bacterial counts at 6 months. *Porphyromonas gingivalis* counts were higher in cases with progressive peri-implantitis                                                                                            At 1 month, *P. aeruginosa*, *S. aureus*, and *S. anaerobius* were reduced in the air-abrasive group, and *Fusobacterium spp.* were reduced in the laser group. 6 month data demonstrated that both methods failed to reduce bacterial counts. Clinical improvements were limited.

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  AAD subgingival\                 OHI patients received a sonic toothbrush                           AAD subgingival\                                                                                                                         21                           45                                                                                                   PD reductions: 0.8 (0.5)                                                                                                   Statistical analyses failed to demonstrate differences in bone-level changes between baseline and 6 months   Statistical analyses also failed to demonstrate differences in the BOP at 6 weeks after treatment   NA                           NA                                   NA                         NA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  polishing                                                                                           polishing for 15 sec in each position                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Riben-Grundstrom et al. \[27\]   2015                                                               RCT                                                                                                                                      Glycine\                     OHI                                                                                                  Glycine powder air-polishing was performed at baseline, 3 and 6 months. Supragingival DE was provided at month 9 and 12.   18                                                                                                           NA                                                                                                  12                           Mucositis                            NA                         NA                                                                                                           43.9 (7.3) to 12.1 (3.8)                                                                            No differences were\   Implant 25.5 (6.8) to\   NA                No differences were\   NA                                                                                                                                                                                                                                                 Non-surgical treatment with a glycine powder air-polishing or ultrasonic device is effective in reducing inflammation and number of peri-implant pockets subject to patient compliance
                                                                                                                                                                                                                                               powder air-polishing group                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  found                  5.6 (3.8)                                  found                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Ultrasonic group                 OHI                                                                Cleaning with ultrasonic was performed at baseline, 3 and 7 months. Supragingival MD was provided at month 9 and 12.                     18                           NA                                                                                                   NA                                                                                                                         NA                                                                                                           53.7 (7.9) to 18.6 (6.4)                                                                            No differences were\         Implant 24.1 (6.6) to\               NA                         No differences were\                                                                                         NA                                                                                                                                                                                                                                                                                                                                                                                                                                              
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             found                        7.4 (6.4)                                                       found                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Swierkot et al. \[28\]           2013                                                               RCT                                                                                                                                      Sonic toothbrush group       Brush 2 min twice daily with\                                                                        NA                                                                                                                         35                                                                                                           Mean count:\                                                                                        12                           No peri-implantitis, 22% mucositis   3.4 (0.88)\                NA                                                                                                           0.22 (0.3) to 0.27 (0.26)                                                                           NA                     0.86 (0.73)to\           4.64 (1.63) to\   1.23 (1.33) to\        After 12 months, both groups exhibited a small increase in total bacterial load at implants and teeth. *P gingivalis*, *P micra* and *D. pneumosintes* were consistently detected at nearly every examination time for implant and teeth groups.   No difference between sonic and manual tooth brushing for plaque reduction at implants and teeth. Sonic and manual toothbrushes maintained clinical, microbiological and immunological parameters over a period of 12 months at implants and teeth with no signs of soft tissue damage or technical complications.
                                                                                                                                                                                                                                                                            toothpaste, brush their teeth with sonic tooth brush according to the manufacturer\'s instructions                                                                                                                                                                                                                                           4.19                                                                                                                                                                  to\                                                                                                                                                                                                                                                                1 (0.79)                 5.1 (1.78)        1.7 (1.48)                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               3.4 (0.8)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Manual toothbrush group          Brush 2 min twice daily with toothpaste, modified Bass technique   NA                                                                                                                                       36                           Mean count:\                                                                                         No peri-implantitis,\                                                                                                      3.13 (0.75)\                                                                                                 NA                                                                                                  0.19 (0.28) to 0.28 (0.38)   NA                                   0.56 (0.52) to\            4.41 (1.65) to\                                                                                              1.28 (1.26) to\                                                                                                                                                                                                                                                                                                                                                                                                                                 
                                                                                                                                                                                                                                                                            4.32                                                                                                 19% mucositis                                                                                                              to\                                                                                                                                                                                                                                                                                0.92 (0.93)                4.43 (1.28)                                                                                                  1.29 (0.85)                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            3.13 (0.78)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AAD = air-abrasive device; BOP = bleeding on probing; CAL = clinical attachment level; CHX = chlorhexidine digluconate; DE = debridement; LD = local delivery; MBL = marginal bone level; MD = mechanical debridement; MPI = modified plaque index; NA = not available; OHI = oral hygiene instructions; PD = probing depth; PI = plaque index; RB = radiographic bone; RCT = randomized controlled trials; SD = standard deviation.

###### 

Characteristics of the included articles

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                    Year of\                                  Type of\                           Groups                             Treatment provided                                                N\                                                                                N\                       Follow-up\      Diagnosis      Treatment outcomes   Microbiological\    Conclusions                                                                                                               
                           publication                               study                                                                                                                                   patients                                                                          implants                 (months)                                            results                                                                                                                                       
  ------------------------ ----------------------------------------- ---------------------------------- ---------------------------------- ----------------------------------------------------------------- --------------------------------------------------------------------------------- ------------------------ --------------- -------------- -------------------- ------------------- ------------------------ ------------------------- ---- --------------------------- ------------------- ------------ ---- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gomes et al. \[29\]      2015                                      Single-arm cohort                  Test                               Multi-tufted TB, dental floss and/or interdental TB.\             Weekly supragingival/\                                                            14                       59              13             Mucositis            3.62 (0.31)\        NA                       Sites:\                   NA   18.98 (5.89)\               NA                  NA           NA   The supragingival-supramucosal biofilm control benefited both teeth and implants
                                                                                                                                           Non-therapeutic fluoride toothpaste                               supramucosal\                                                                                                                                                  to\                                          54.05 (5.88)\                  to\                                                               
                                                                                                                                                                                                             MD for 1 month,\                                                                                                                                               2.55 (0.16)                                  to\                            2.7 (1.47)%\                                                      
                                                                                                                                                                                                             then every 3 months                                                                                                                                                                                         4.96 (1.78)%                   /390 days                                                         

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Corbella et al. \[30\]   2011                                      Non-controlled prospective study   Mucositis                          CHX 0.2% mouthwash twice a day for 10 days, interdental brushes   Powered and manual devices MD                                                     61                       244             60             Mucositis            2.2 (0.87)\         NA                       Sites:\                   NA   Sites/6 and 58 months\      NA                  NA           NA   Systematic hygienic protocol is effective in keeping low the incidence of peri-implant mucositis as well as in controlling plaque accumulation and clinical attachment loss.
                                                                                                                                                                                                                                                                                                                                                                            to\                                          Index 0: 88.2 to 100%\         Index 0: 58.3% to 88.5%;\                                         
                                                                                                                                                                                                                                                                                                                                                                            2.46 (0.5)                                   Index 1: 1.4 to 0%;\           Index 1: 2.8 to 7.3%;\                                            
                                                                                                                                                                                                                                                                                                                                                                                                                         Index 2: 10.4 to 0%;\          Index 2: 9.7 to 1%;\                                              
                                                                                                                                                                                                                                                                                                                                                                                                                         Index 3: 0 to 0%.              Index 3: 29.2 to 3.2%                                             

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Peri-implantitis         CHX 0.2% mouthwash, interdental brushes   Powered and manual devices\        Peri-implantiti                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                     + LD of CHX 1%\                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                     + Sx MD                                                                                                                                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Costa et al. \[31\]      2012                                      Prospective study                  Control                            No                                                                No                                                                                41                       183             60             Mucositis            16.7% sites\        41.5% implants show BL   Sites:\                   NA   1.6 (0.6)\                  \% sites \> 3 mm\   NA           NA   The absence of preventive maintenance in individuals with pre-existing peri-implant mucositis was associated with a high incidence of peri-implantitis.
                                                                                                                                                                                                                                                                                                                                                                            with\                                        50.2 to 62.6%                  to\                         CAL\                                  
                                                                                                                                                                                                                                                                                                                                                                            PD ≥ 5 mm                                                                   1.9 (0.5)                   14.9 (16.7)\                          
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    to\                                   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    22.7 (23.2)                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Test                     OHI                                       At least 5 SC,\                    39                                 157                                                               5.9% sites\                                                                       17.9% implants show BL   Sites:\         NA             1.4 (0.6)\           \% sites \> 3 mm\   NA                       NA                                                                                               
                                                                     coronal prophylaxis                                                                                                                     with\                                                                                                      41.7 to 33.3%                  to\                  CAL\                                                                                                                                          
                                                                                                                                                                                                             PD ≥ 5 mm                                                                                                                                 1.4 (0.7)            15.9 (19)\                                                                                                                                    
                                                                                                                                                                                                                                                                                                                                                                            to\                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                                            20.1 (23)                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Deppe et al. \[32\]      2013                                      Prospective study                  Moderate bone loss                 OHI, plaque control with use of CHX solution (0.3%)               Calculus removal\                                                                 16                       10              6              Peri-implantitis     3.3 (0.8)\          3.9 (0.8)\               Sulcus bleeding index:\   NA   NA                          3.8 (1.3)\          0.5 (0.5)\   NA   Non-surgical PDT could stop bone resorption in moderate peri-implant defects but not in severe defects. marginal tissue recession was not significantly different in both groups.
                                                                                                                                                                                                             + antimicrobial PDT                                                                                                                                            to\                 to\                      1.8 (1.3)\                                                 to\                 to\               
                                                                                                                                                                                                                                                                                                                                                                            2.9 (0.5)           3.6 (0.8) mm             to\                                                        3.6 (0.7)           0.7 (0.4)         
                                                                                                                                                                                                                                                                                                                                                                                                                         1.1 (0.9)                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Severe bone lost         8                                         5.8 (0.8)\                         6.8 (0.8)\                         Sulcus bleeding index:\                                           NA                                                                                NA                       6.7 (0.9)\      0.9 (1.2)\     NA                                                                                                                                                                 
                                                                     to\                                to\                                1.5 (1.2)\                                                                                                                                                                   to\             to\                                                                                                                                                                               
                                                                     6.5 (0.9)                          8.7 (0.7)                          to\                                                                                                                                                                          8.1 (0.9)       1.6 (1.2)                                                                                                                                                                         
                                                                                                                                           1.3 (1.1)                                                                                                                                                                                                                                                                                                                                                                      

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Schwarz et al. \[33\]    2015                                      Prospective case series            MD + local antiseptic (MD + CHX)   OHI                                                               Supragingival calculus removal and supramucosal/gingival professional implant/\   17                       24              6              Mucositis            3.4 (0.5)\          NA                       46.3 (23.5)\              NA   0.7 (0.6)\                  NA                  NA           NA   Non-surgical treatment of either peri-implant mucositis using MD + CHX or peri-implantitis using laser therapy at zirconia implants was associated with significant short-term clinical improvements. A complete disease resolution, however, was not achieved in the majority of the patients.
                                                                                                                                                                                                             tooth cleaning\                                                                                                                                                to\                                          to\                            to\                                                               
                                                                                                                                                                                                             + MD + CHX                                                                                                                                                     3.3 (0.5)                                    8.3 (10.4)%                    0.4 (0.5)                                                         

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  Er:YAG laser therapy     OHI                                       Supragingival calculus removal\    17                                 21                                                                Peri-implantitis                                                                  5.5 (0.5)\               NA              45 (18.5)\     NA                   0.6 (0.3)\          NA                       NA                        NA                                                                     
                                                                     and supramucosal/\                                                                                                                                                                                                        to\                                      to\                                 to\                                                                                                                                           
                                                                     gingival professional implant/\                                                                                                                                                                                           4.5 (0.7)                                14.2 (11.6)%                        0.1 (0.1)                                                                                                                                     
                                                                     tooth cleaning\                                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                     + laser tx                                                                                                                                                                                                                                                                                                                                                                                                                                           
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ABX = antibiotics treatment; BOP = bleeding on probing; CAL = clinical attachment level; CHX = chlorhexidine digluconate; LD = local delivery; MBL = marginal bone level; MD = mechanical debridement; MPI = modified plaque index; NA = not available; PD = probing depth; PDT = photodynamic therapy; PI = plaque index; RB = radiographic bone; SD = standard deviation; Sx = surgery; TB = tooth brush.

###### 

Characteristics of the included articles: description of affected sites, implant characteristics, prosthetic factors)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                            Groups                         Description of affected sites   Implant characteristics   Prosthetic factors      Additional\                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                                                    info                                                                                                                                                                                                                                                                                                                                                           
  -------------------------------- ------------------------------ ------------------------------- ------------------------- ----------------------- ---------------------------------------------------------------------- ------------- ------------- ---------------------------------------------------------------------- ---------------------- -------------------------------------------------------------------- ------------------- ---- ----------------- --------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------
  Arisan et al. \[20\]             Control                        4 to 6                          \< 3 mm MBL               Yes                     And/or suppuration                                                     NA            NA            Multiple                                                               19.4 months            Rough (acid etching\                                                 Cemented            NA   NA                Fixed metal-ceramic prostheses                Suprastructures removed for measurements
                                                                                                                                                                                                                                                                                                                                                     and sand blasting)                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Test                             4 to 6                         \< 3 mm MBL                     Yes                       And/or suppuration      NA                                                                     NA            19.4 months   Rough (acid etching\                                                   Cemented               NA                                                                   NA                                                                                       
                                                                                                                                                                                                                                                       and sand blasting)                                                                                                                                                                                                                                          

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Bassetti et al. \[21\]           Control: LDD                   4 to 6                          0.5 to 2                  Yes                     NA                                                                     2.72 (0.72)   1.68 (1.04)   Straumann tissue level                                                 7.2 (2.6 - 15) years   SLA                                                                  Screwed             NA   NA                NA                                            NA

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Test: PDT                        4 to 6                         0.5 to 2                        2.66 (0.73)               1.53 (0.91)             7.3 (4 - 14.8) years                                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Esposito et al. \[22\]           Control                        Deepest pocket only: 6.45       Mean 4.73 (2.11)          Yes                     Pus exudation and/or soft tissue swelling and/or soft tissue redness   NA            NA            NA                                                                     6.13 years             NA                                                                   NA                  NA   NA                NA                                            In some of the Sx treated cases, unsupported threads were removed and polished based on the clinician\'s decision

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Test                             Deepest pocket only: 6.23      Mean 4.4 (1.58)                 5.65 years                                                                                                                                                                                                                                                                                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Hallstrom et al. \[23\]          Control                        ≥ 4                             \< 2mm bone loss          Yes                     And/or\                                                                NA            NA            Multiple                                                               10.9 years             NA                                                                   Cemented: 52.6%;\   NA   NA                NA                                            NA
                                                                                                                                                    suppuration                                                                                                                                                                                                                                                           Screwed: 47.4%                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Test                             10 years                       Cemented: 59.1%;\                                                                                                                                                                                                                                                                                                                                                                                                                                
                                                                  Screwed: 40.9%                                                                                                                                                                                                                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  John et al. \[24\]               AAD                            ≥ 4                             Loss of\                  Yes                     Yes                                                                    5.2 (1.9)     1.5 (1.4)     Multiple                                                               NA                     Machined surface,\                                                   Screwed             NA   Single tooth\     NA                                            Without overhangings or margins
                                                                                                  supporting bone\                                                                                                                                                                                                                                   microrough surface                                                                            and bridgework\                                                 
                                                                                                  ≤ 30%                                                                                                                                                                                                                                                                                                                                            restorations                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  MD (carbon curettes\             5 (1.5)                        1 (1.1)                                                                                                                                                                                                                                                                                                                                                                                                                                          
  + local antiseptic therapy)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Machtei et al. \[25\]            Control                        6 to 10                         ≥ 2                       Yes                     NA                                                                     7.63 (0.3)    NA            NA                                                                     NA                     Exclude Titanium Plasma-sprayed or hydroxylapatite coated implants   NA                  NA   NA                NA                                            NA

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Test                             7.88 (0.2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Persson et al. \[26\]            Er:YAG laser                   ≥ 5                             ≥ 2                       Yes                     And/or\                                                                NA            NA            NA                                                                     NA                     Machined surfaces\                                                   NA                  NA   NA                NA                                            Superstructures were removed to enhance assessments of PD and BOP and to improve the ability to collect bacterial samples.
                                                                                                                                                    suppuration                                                                                                                                                                                      and medium-rough\                                                                                                                                             
                                                                                                                                                                                                                                                                                                                                                     surfaces                                                                                                                                                      

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  AAD subgingival polishing        ≥ 6                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Riben-Grundstrom et al. \[27\]   Glycine powder air-polishing   ≥ 4                             ≤ 2                       Yes                     And/or\                                                                NA            NA            Multiple                                                               NA                     NA                                                                   NA                  NA   NA                NA                                            NA
                                                                                                                                                    suppuration                                                                                                                                                                                                                                                                                                                                                    

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Ultrasonic debridement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Swierkot et al. \[28\]           Sonic toothbrush group         ≥ 5                             \< 1                      Yes/\                   NA                                                                     4.64          1.24          Nobel Replace Straight Groovy                                          At least 12 months     Rough                                                                Screwed             NA   NA                Single implant or fixed prosthesis            NA
                                                                                                                            no                                                                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Manual toothbrush group          ≥ 6                            4.41                            1.28                      At least 13 months                                                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Gomes et al. \[29\]              Test                           2.23 (0.09)                     NA                        Yes                     NA                                                                     NA            NA            Nobel Biocare                                                          5.7 (2.5) years        NA                                                                   NA                  NA   NA                NA                                            NA

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Corbella et al. \[30\]           Mucositis                      NA                              NA                        Bleeding index ≥ 2      NA                                                                     NA            NA            NA                                                                     NA                     NA                                                                   NA                  NA   NA                Immediately loaded full-arch rehabilitation   NA

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Peri-implantitis                 \> 4                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Costa et al. \[31\]              Control                        \> 5                            No                        Yes                     Yes                                                                    NA            NA            Multiple                                                               80.5 months            NA                                                                   NA                  NA   NA                Single crowns and/\                           NA
                                                                                                                                                                                                                                                                                                                                                                                                                                                                     or fixed partial prosthetic                   

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Test                             77.4 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Deppe et al. \[32\]              Moderate bone loss             \< 5                            3.9 (0.8)                 Yes                     NA                                                                     3.8 (1.3)     0.5 (0.5)     NA                                                                     NA                     NA                                                                   NA                  NA   NA                NA                                            All restorations were left in situ

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Severe bone lost                 5 to 8                         6.8 (0.8)                       6.7 (0.9)                 0.9 (1.2)                                                                                                                                                                                                                                                                                                                                                                              

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Schwarz et al. \[33\]            MD + local antiseptic\         NA                              No                        Yes                     No                                                                     NA            NA            Zirconia implants (ZV4, Zircon Vision GmbH, Wolfratshausen, Germany)   NA                     Modified (roughness:\                                                Screwed             NA   NA                NA                                            NA
                                   (MD + CHX)                                                                                                                                                                                                                                                                                                        Ra = approx. 7 μm/\                                                                                                                                           
                                                                                                                                                                                                                                                                                                                                                     Rz = approx. 41 μm)                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Er:YAG laser therapy             ≥ 6                            Changes in RB level             And/or\                   Modified (roughness:\                                                                                                                                                                                                                                                                                                                                                                  
                                                                                                  suppuration               Ra = approx. 7 μm/\                                                                                                                                                                                                                                                                                                                                                                    
                                                                                                                            Rz = approx. 42 μm)                                                                                                                                                                                                                                                                                                                                                                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AAD = air-abrasive device; BOP = bleeding on probing; CAL = clinical attachment level; CHX = chlorhexidine digluconate; LD = local delivery; MBL = marginal bone level; MD = mechanical debridement; NA = not available; PD = probing depth; PDT = photodynamic therapy; RB = radiographic bone; SD = standard deviation; SLA = sandblasted and acid-etched implant.

**Excluded studies**

The reasons for exclusion are summarized in [Table 3](#T3){ref-type="table"}. Four articles presented with short follow up with less than 6 months \[[@B10]\], two articles were retrospective in design \[[@B6],[@B14]\], one investigation was a review study \[[@B15]\], three articles employed the same study population than other included investigations in the present analysis \[[@B16]\], and 1 investigation presented with unclear and incomplete data \[[@B19]\].

###### 

Excluded articles with reasons for exclusion

  -------------------------------------------------------------------------------------
  Study                           Year of\      Reasons for exclusion
                                  publication   
  ------------------------------- ------------- ---------------------------------------
  Mettraux et al. \[6\]           2015          Retrospective study

                                                

  Heitz-Mayfield et al. \[10\]    2011          Short follow-up

                                                

  Ji et al. \[11\]                2014          Short follow-up

                                                

  McKenna et al. \[12\]           2013          Short follow-up

                                                

  Mussano et al. \[13\]           2013          Short follow-up

                                                

  Lerario et al. \[14\]           2016          Retrospective study

                                                

  Parma-Benfenati et al. \[15\]   2013          Review

                                                

  Renvert et al. \[16\]           2011          Same sample as Persson et al. \[26\]

                                                

  Sahm et al. \[17\]              2011          Same sample as John et al. \[24\]

                                                

  Schär et al. \[18\]             2013          Same sample as Bassetti et al. \[21\]

                                                

  Sreenivasan et al. \[19\]       2011          Unclear and incomplete data
  -------------------------------------------------------------------------------------

**Study characteristics**

The characteristics of the 14 included articles are summarized in [Tables 1](#T1A){ref-type="table"} and [2](#T2){ref-type="table"}. The publications include several study types: 9 randomized controlled trials (RCTs) with parallel designs \[[@B20]\], 1 single-armed cohort study \[[@B29]\], 4 non-controlled prospective studies and case series \[[@B30]\]. The follow-up periods of the studies ranged from 6 to 60 months. There were several different definitions regarding peri-implant mucositis and peri-implantitis, being the definitions for peri-implantitis more variable than those of mucositis. In the Deppe et al. \[[@B32]\] study, they classified peri-implantitis into moderate and severe groups based on the severity of the bone loss.

Most articles reported the subject numbers as well as the implants evaluated in the studies, however 3 articles failed to report the numbers of the implants that were evaluated in the studies \[[@B23],[@B24],[@B27]\] while 1 article only presented the mean number of implants for each patient \[[@B28]\].

Regarding the description of the diseased sites, most studies provided information on PPD and BOP of the affected implants, however, 2 articles did not present PPD for the implants affected by mucositis \[[@B30],[@B33]\]. Eleven articles reported RB loss \[[@B20],[@B32],[@B33]\]. Some articles reported on the implant characteristics including the systems and the surface materials, implant functioning time and the prosthetic design \[[@B20],[@B27],[@B31],[@B33]\]. One study particularly excluded implants with titanium plasma sprayed or hydroxyapatite coated implants \[[@B25]\]. Five articles performed microbial test \[[@B20],[@B21],[@B23],[@B26],[@B28]\]. Some articles reported the locations (i.e. maxilla or mandible; anterior or posterior) of the implants evaluated in the studies, however, none of the articles presented the bucco-lingual position of the implants and no articles reported the possible aetiology and/or contributory factors of peri-implant mucositis or peri-implantitis. Treatment interventions of individual studies

Most of the studies included oral hygiene instructions of using interdental brushes or other required techniques indicated in the protocol before initiating different treatment modalities \[[@B20],[@B21],[@B23],[@B31]\]. One study reported self-performed cleaning techniques including certain toothpaste and toothbrush \[[@B28]\]. One article presented the model of systemic administration of antimicrobial agent \[[@B23]\] while Bassetti et al. \[[@B21]\] in 2014 reported the effect of locally delivered antibiotics adjunct to scaling and root planning (SRP) and air-polishing; and another article evaluated the effect of chlorhexidine chip (Perio^®^ chip) in treating peri-implantitis \[[@B25]\]. Of importance to mention is that Bassetti and colleagues \[[@B21]\] repeated the treatment in BOP positive sites after 3, 6, 9, and 12 months. Other professional-performed interventions that were presented in the articles include laser, photodynamic therapy, supra-/sub-mucosal mechanical debridement, and air-abrasive devices. Four articles reported the use of lasers in conjunction to SRP \[[@B20],[@B22],[@B26],[@B33]\]. Lasers employed were diode laser \[20\], Er:YAG laser \[[@B26],[@B33]\] and light-activated disinfection treatment (FotoSan). Three other articles reported on photodynamic therapy \[[@B21],[@B22],[@B32]\].

**Treatment outcomes**

PPD was reported as direct or the percentage change except one article \[[@B27]\]. Majority of studies demonstrated that the change of PPD are within 1 mm. Bleeding index or the percentage of BOP also decreases after different treatment modalities in most of the studies. Regarding the laser studies, 3 studies showed that there were no additional positive effect beyond the traditional mechanical debridement and had limited influence in treating peri-implantitis \[[@B20],[@B22],[@B26]\] while other one article presented significant clinical improvement \[[@B21]\]. Regarding self-performed hygiene techniques, most of the studies demonstrated that with the application of hygiene protocol, it is effective to improve clinical parameters and also keeping the low incidence of developing peri-implant mucositis \[[@B28]\]. For professional-performed mechanical debridement, studies in general demonstrated effectiveness in reducing inflammation and PPD \[[@B24],[@B27],[@B30]\].

**Assessment of methodological quality**

The results of risk of bias assessment for included RCTs were summarized in [Table 4](#T4){ref-type="table"}. In addition, 6 studies were non-RCT and qualitative assessments were analysed with NOS. The mean NOS score for the evaluated studies was 6 ± 1.

###### 

Risk of bias assessment of the included studies

  ----------------------------------------------------------------------------------------------------------------------------------
  Study                            Random\      Allocation\   Blinding of\        Blinding of\   Incomplete\   Selective\   Other\
                                   sequence\    concealment   participants and\   outcome\       outcome\      reporting    bias
                                   generation                 personnel           assessment     data                       
  -------------------------------- ------------ ------------- ------------------- -------------- ------------- ------------ --------
  Arisan et al. \[20\]             \+           \-            \-                  ?              \+            \+           ?

                                                                                                                            

  Bassetti et al. \[21\]           \+           \-            \-                  \+             \+            \+           ?

                                                                                                                            

  Esposito et al. \[22\]           \+           \-            \-                  \+             \+            \+           \+

                                                                                                                            

  Hallström et al. \[23\]          \+           \+            \-                  \-             \+            \+           \+

                                                                                                                            

  John et al. \[24\]               \+           \-            \-                  \+             \+            \-           ?

                                                                                                                            

  Machtei et al. \[25\]            \+           \+            \+                  \+             \+            \+           ?

                                                                                                                            

  Persson et al. \[26\]            \+           \-            \-                  ?              \+            \+           ?

                                                                                                                            

  Riben-Grundstrom et al. \[27\]   \+           \+            \-                  \+             \+            \-           ?

                                                                                                                            

  Swierkot et al. \[28\]           \+           \-            \-                  \+             \+            \+           \+
  ----------------------------------------------------------------------------------------------------------------------------------

\+ = low risk; ? = unclear risk; - = high risk.

DISCUSSION
==========

Dental implants have become the gold standard when aiming at reconstruction of the missing dentition. Decades of investigation have proven dental implants to be reliable alternative providing function and aesthetics with long-term success. However, with the increasing number of fixtures being installed yearly, there has also been a significant increase in the number of patients suffering from peri-implant diseases. According to a recent systematic review peri-implant mucositis and peri-implantitis have a prevalence ranging from 19 to 65% and from 1 to 47%, respectively. On the other hand, mean prevalence for peri-implant mucosistis and peri-implantitis are 43% and 22%, respectively \[[@B34]\]. Consequently, treatment of peri-implant diseases has become one of the main focus of the investigations in periodontology. During the last decades, this inflammatory condition has witnessed a tremendous advance in terms of understanding of its aetiology as well as the surgical management. As an example, studies focusing on the different aspects of this disease have been multiplied by more than 100 times during the last two decades.

While initially thought as a periodontitis like lesion surrounding a dental implant, peri-implantitis has recently been related to multiple other variables. In fact, there are a great variety of factors that have been related with marginal bone loss (MBL) and/or peri-implantitis that often differ with the ones associated with periodontitis. To name a few: surgical trauma, infection, plaque and poor oral hygiene, alcohol and tobacco consumption, as well as biological bone remodelling \[[@B35]\]. Moreover, the possible existence of an imbalance between the implant fixture and the surrounding bone has recently been proposed as a possible etiological factor. Although solely based on narrative reviews \[[@B39]\], the hypothesis of a foreign body reaction as another causative agent for MBL has also been proposed \[[@B40]\]. In addition, the influence of the different implant surfaces and the presence of titanium particles embedded into the surrounding peri-implant tissues have been recently investigated.

Regardless of the aetiology of the peri-implant diseases, multiple investigations are being conducted trying to elucidate the most effective treatment approach. However, while the determination of the most effective treatment seems a challenging duty and over the years conflicting results have been shown, the importance of prevention for prompt intervention seems to be in agreement by researchers. Today, the prevention as well as early detection of peri-implant mucositis remains as key components in successful dental implantology. These statements are supported by the effectiveness in treatment of mucositis while treatment of peri-implantitis remains unpredictable. Consequently, current evidence shows that peri-implant mucositis can be successfully treated by non-surgical therapy. Locally delivered antibiotics, lasers, mechanical sub- and supra- gingival SRP, as well as air-polishing, among others can be used for the non-surgical treatment of peri-implant mucositis. In addition, repeated treatment of diseased sites seems to be effective.

Substantial improvements are to be made in research regarding treatment of peri-implantitis and peri-implant mucositis. It is of paramount importance the identification of both local and systemic factors affecting the incidence and severity of such conditions for the proper management. Now a day, most of the investigations have failed to provide proper documentation with regard to implant system and position, which have been demonstrated to be significant contributing factors influencing the clinical outcome of different treatment modalities. Moreover, depending on the presence and severity of these local and systemic factors, in many instances, the treatment of choice should be explanation of the fixture.

**Limitations**

Within the limitation of the present investigations, the major drawback is the multitude of different definitions regarding peri-implant mucositis and peri-implantitis that were employed in the included investigations. Also, multiple different treatment approaches, different implant designs as well as surface characteristics, and wide variation in terms of follow-up periods may have played a role in the treatment outcomes.

CONCLUSIONS
===========

Multitude of different treatment approaches is available for the non-surgical treatment of peri-implant diseases. While significant variations exist in term of treatment outcomes, the non-surgical treatment seems to effective for peri-implant mucositis. Self-performed hygiene techniques are effective improving clinical parameters and maintaining a low incidence of developing peri-implant mucositis. Professional-performed mechanical debridement is effective in reducing inflammation and pocket depths.
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